Trial Condition(s):

Bacterial Infections

Ciprofloxacin versus Continued Parenteral Ceftazidime in Neutropenic Pediatric Cancer Patients who have Responded to Initial Parenteral Therapy

Bayer Identifier:

Trial_1310

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
14
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Cipro (Ciprofloxacin hydrochloride, BAYO9867)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information